Health Metric Claims on New Wearables: Separating Validated Features from Unproven Ones

The FDA distinguishes between general wellness products and medical devices. Most smartwatch health features — including sleep staging, stress scores, and readiness indexes — fall under the general wellness category, which requires far less regulatory scrutiny. Only specific features, like certain ECG applications and AFib (atrial fibrillation) detection tools, have obtained individual FDA clearance. A device being sold in a retail store tells you almost nothing about whether its health features have been clinically validated.

A clinical ECG uses 12 electrodes placed across the body to capture a detailed electrical picture of the heart from multiple angles. Wearable ECGs typically use one lead — a circuit between the wrist sensor and a finger pressing a button — which gives a much narrower view. FDA-cleared wearable ECG apps are approved specifically to look for irregular heart rhythms consistent with AFib, not to diagnose other cardiac conditions. Using a wearable ECG reading to rule out cardiac problems beyond AFib goes well beyond what the technology is designed or validated to do. Research on wearable accuracy reinforces how narrow these validated use cases actually are.

Heart rate variability (HRV) — tiny fluctuations in the time between heartbeats — is a legitimately studied physiological signal associated with autonomic nervous system activity. However, how each wearable brand translates raw HRV data into a "stress score" or "readiness score" is largely proprietary and varies significantly between devices. No universal clinical standard governs what these scores mean or how they should be used. They can offer rough directional signals, but treating them as precise physiological measurements overstates what the technology actually delivers.

Non-invasive glucose monitoring — detecting blood sugar levels without breaking the skin — is one of the most actively pursued challenges in wearable health tech. Multiple companies have announced features in this space, and some devices offer glucose "trend" indicators. However, the gap between a trend estimate and an accurate, actionable blood glucose reading is significant. People managing conditions like diabetes require clinically accurate readings, and consumer wearable features marketed around glucose should be interpreted with caution until peer-reviewed validation and regulatory clearance are in place. See the sensor limitations guide for more context on what optical sensors can physically detect.

Pulse oximetry on medical-grade devices measures blood oxygen saturation with high precision. Consumer wearable versions use similar optical technology — shining light through the skin and measuring absorption — but at lower hardware fidelity and without the same calibration standards. The FDA has issued guidance highlighting that pulse oximeter accuracy varies across skin tones, a gap that has been documented in research studies. For healthy users tracking general wellness trends, wearable SpO2 can be informative. For people with respiratory or cardiovascular conditions who need precise readings, a cleared medical oximeter is a different category of device entirely.